Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...

The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

Since approval, the Food and Drug Administration has received additional reports of hematologic malignancies, including ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

The following is a summary of “Autologous Peripheral Blood-Derived Orthobiologics for the Management of Shoulder Disorders: A ...

The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen ...

SINGAPORE I5, 2024 I SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for ...

As a result of the follow-up observation of patients who received BMAC intra-articular injection procedures by Himchan ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

SÖDERTÄLJE, Sweden I6, 2024 I Anocca AB, a leading T-cell receptor-engineered T-cell (TCR-T) cellular therapeutics company, announces the ...

Anocca has submitted its first clinical trial application (CTA) to the European Medicines Agency (EMA) for conducting the ...

Francis S. Kim, MD, has made significant contributions to biomedical research and clinical care for adult and pediatric ...